Live Breaking News & Updates on தாது எலும்பு

Stay updated with breaking news from தாது எலும்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Spinal Imaging Test Predicts the Likelihood of Bone Fractures in Older Men


Spinal Imaging Test Predicts the Likelihood of Bone Fractures in Older Men
by Hannah Joy on 
March 17, 2021 at 11:33 AM
A new study published in the
Journal of Bone and Mineral Research that included 5,365 older men indicates that each of these measures are linked with a higher risk of developing hip and other fractures.
Investigators found that including both measures compared with including only abdominal aortic calcification or only vertebral fractures improved the ability to predict which men were most likely to experience a hip or other fracture in the future.
‘Abdominal aortic calcification and a prevalent vertebral fracture can be simultaneously and quickly detected on standard radiographs or lateral spine bone density images.’ ....

Johnt Schousboe , Hyperostosisundescended Testiclesvaricoceletesticle , University Of Minnesota , Mineral Research , Park Nicollet Clinic Healthpartners Institute , Park Nicollet Clinic , Osteoporosis Day , Targeted Therapy , Bone Fractures , Drinking Green Tea , Coffee Lower Death , Cortical Hyperostosis , Mineral Bone , Mineral Bone Disorder , Evaluationrenal Osteodystrophy , Bone Fractures In Old Men , Spinal Fracture , Hip Fracture In Elderly , Spinal Imaging Test , பல்கலைக்கழகம் ஆஃப் மினசோட்டா , தாது ஆராய்ச்சி , பூங்கா நிக்கோலெட் சிகிச்சையகம் சுகாதார பங்குதாரர்கள் நிறுவனம் , பூங்கா நிக்கோலெட் சிகிச்சையகம் , அஸ்டீயாப்ரோஸிஸ் நாள் , இலக்கு சிகிச்சை , எலும்பு எலும்பு முறிவுகள் ,

New Drugs Hold Promise to Treat Blood, Bone Marrow Cancers


New Drugs Hold Promise to Treat Blood, Bone Marrow Cancers
by Angela Mohan on 
December 16, 2020 at 3:06 PM
Blood Cancer Discovery.
Myeloid leukemias are cancers derived from stem and progenitor cells in the bone marrow that give rise to all normal blood cells.
One of the most common mutations involved in driving myeloid leukemias are found in the TET2 gene, which has been investigated for the last decade by Jaroslaw Maciejewski, MD, PhD, a practicing hematologist and chair of the Cleveland Clinic Department of Translational Hematology & Oncology Research.
In the new study, Dr. Maciejewski and his collaborator in the Department of Translational Hematology & Oncology Research, Babal Kant Jha, PhD, report a new pharmacological strategy to preferentially target and eliminate leukemia cells with TET2 mutations. ....

Babal Kant Jha , Jaroslaw Maciejewski , Biopsydrug Toxicityleucopenia Leukopeniainfantile , Hodgkins Lymphomamultiple Myelomadrugs , Lisa Ray , James Phillips , Transplantationrenal Osteodystrophy , Cleveland Clinic Taussig Cancer Institute , Lerner Research Institute , Department Of Translational Hematology Oncology Research , Cleveland Clinic , Taussig Cancer Institute , Lerner Research , Blood Cancer , Cleveland Clinic Department , Translational Hematology , Oncology Research , Drug Can Improve Survival , Marrow Aspiration , Cortical Hyperostosis , Deepa Mehta , Hodgkins Lymphoma , Mineral Bone , Mineral Bone Disorder , Biopsydrug Toxicityleucopenia , பாபல் காந்த் ஜா ,